Brief: Eloxx Pharmaceuticals Reports First Quarter 2023 Financial And Operating Results And Provides Business Update

Eloxx Pharmaceuticals

15/05/2023 22:45

Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS REPORTS FIRST QUARTER 2023 FINANCIAL
AND
OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
    * ELOXX PHARMACEUTICALS INC - QTRLY NET LOSS OF $2.88 PER
SHARE
    * ELOXX PHARMACEUTICALS INC - AS OF MARCH 31, 2023, HAD
UNRESTRICTED CASH AND CASH EQUIVALENTS OF $4.9 MILLION
    * ELOXX PHARMACEUTICALS - EXPECTS CURRENT CASH POSITION WILL
BE
SUFFICIENT TO FUND OPERATIONS INTO Q3 2023

Source text for Eikon:  ID:nGNX4QT8yR 
Further company coverage:  ELOX.O